WELLINGTON MANAGEMENT GROUP LLP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 118 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$227,000
-68.0%
316,863
+0.9%
0.00%
Q4 2021$710,000
-98.3%
314,062
-97.1%
0.00%
-100.0%
Q2 2021$40,692,000
+10.9%
10,736,859
-0.9%
0.01%
+16.7%
Q1 2021$36,687,000
+4.1%
10,838,165
-13.9%
0.01%0.0%
Q4 2020$35,253,000
+77.2%
12,590,463
+58.9%
0.01%
+50.0%
Q3 2020$19,892,000
-79.9%
7,924,972
+8.9%
0.00%
-81.8%
Q2 2020$98,791,000
+655.3%
7,274,723
+321.6%
0.02%
+633.3%
Q1 2020$13,080,000
+130.8%
1,725,541
+92.4%
0.00%
+200.0%
Q4 2019$5,667,000
+261.2%
896,727
+124.0%
0.00%
Q3 2019$1,569,000
-21.0%
400,293
-2.5%
0.00%
Q2 2019$1,986,000
-40.9%
410,358
-0.0%
0.00%
-100.0%
Q1 2019$3,361,000
+48.3%
410,427
+0.1%
0.00%0.0%
Q4 2018$2,267,000
-37.4%
409,908
+0.0%
0.00%0.0%
Q3 2018$3,619,000
-35.9%
409,833
-27.6%
0.00%0.0%
Q2 2018$5,647,000
-7.8%
565,857
-12.0%
0.00%0.0%
Q1 2018$6,128,000
+9.3%
643,084
+70.6%
0.00%0.0%
Q4 2017$5,605,000
-9.0%
376,926
+20.4%
0.00%0.0%
Q3 2017$6,156,000
+125.0%
312,981
+64.3%
0.00%0.0%
Q2 2017$2,736,000
+95.6%
190,436
+25.3%
0.00%
Q1 2017$1,399,000
+3.8%
152,020
+17.4%
0.00%
Q4 2016$1,348,000
+3.9%
129,500
-9.6%
0.00%
Q3 2016$1,297,000
+21.0%
143,3300.0%0.00%
Q2 2016$1,072,000
-18.2%
143,330
-1.4%
0.00%
Q1 2016$1,310,000145,4000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders